中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

Notch信号通路介导免疫炎症反应参与肝损伤的作用机制

舒发明 黄英 张衎 何发娟 龙富立 毛德文

引用本文:
Citation:

Notch信号通路介导免疫炎症反应参与肝损伤的作用机制

DOI: 10.12449/JCH251134
基金项目: 

国家中医临床研究基地重点病种临床研究项目 (Science and Technology Letter of Traditional Chinese Medicine [2018] No.131);

国家自然科学基金面上项目 (82274434);

国家自然科学基金地区项目 (82360912);

广西中医药多学科交叉创新团队项目 (GZKJ2306)

利益冲突声明:本文不存在任何利益冲突。
作者贡献声明:黄英、张衎、何发娟、龙富立参与修改论文;舒发明、毛德文负责设计论文框架,起草论文,并对文章进行修改,终审论文。
详细信息
    通信作者:

    毛德文, mdwboshi2005@163.com (ORCID: 0000-0001-9438-9325)

Mechanism of action of the Notch signaling pathway in mediating immune inflammatory response in liver injury

Research funding: 

The Clinical Research Project of Key Diseases in the National Clinical Research Base of Traditional Chinese Medicine (Science and Technology Letter of Traditional Chinese Medicine [2018] No.131);

National Natural Science Foundation of China (General Program) (82274434);

National Natural Science Foundation Regional Project (82360912);

Guangxi Traditional Chinese Medicine Multidisciplinary Cross Innovation Team Project (GZKJ2306)

More Information
  • 摘要: 免疫炎症反应贯穿于肝损伤的整个病理过程,然而其具体调控机制尚未完全阐明。近年研究发现,Notch信号通路通过调控巨噬细胞极化、中性粒细胞募集活化及调节性免疫细胞分化等方式,在肝损伤中发挥重要作用。本文系统梳理了Notch信号通路介导免疫炎症反应参与肝损伤的分子机制并总结归纳,旨在为肝脏疾病免疫炎症损伤分子机制的阐明提供新视角,并为未来研究方向提供新的参考。

     

  • 图  1  Notch通路调控巨噬细胞极化机制

    Figure  1.  Mechanism of Notch pathway regulating macrophage polarization

  • [1] LI BL, XU LH. Differential diagnosis of drug-induced liver injury, drug-induced autoimmune hepatitis and autoimmune hepatitis[J]. J Pract Hepatol, 2021, 24( 4): 460- 463. DOI: 10.3969/j.issn.1672-5069.2021.04.002.

    李变利, 徐丽红. 药物性肝损伤、药物诱导性自身免疫性肝炎和自身免疫性肝炎鉴别诊断研究进展[J]. 实用肝脏病杂志, 2021, 24( 4): 460- 463. DOI: 10.3969/j.issn.1672-5069.2021.04.002.
    [2] LI F, WANG S. An excerpt of EASL clinical practice guideline: Occupational liver diseases(2019)[J]. J Clin Hepatol, 2020, 36( 2): 293- 298. DOI: 10.3969/j.issn.1001-5256.2020.02.008.

    李帆, 王帅.《2019年欧洲肝病学会临床实践指南: 职业性肝病》摘译[J]. 临床肝胆病杂志, 2020, 36( 2): 293- 298. DOI: 10.3969/j.issn.1001-5256.2020.02.008.
    [3] SHANG DB, XIANG XG. Advances in the pathogenesis and treatment of acute-on-chronic liver failure[J]. J Clin Hepatol, 2021, 37( 4): 765- 769. DOI: 10.3969/j.issn.1001-5256.2021.04.005.

    尚大宝, 项晓刚. 慢加急性肝衰竭的发病机制和治疗进展[J]. 临床肝胆病杂志, 2021, 37( 4): 765- 769. DOI: 10.3969/j.issn.1001-5256.2021.04.005.
    [4] LIU SQ, YANG JZ, YANG T, et al. Expert consensus on emergency diagnosis and treatment of adult acute liver injury[J]. Chin J Crit Care Med, 2024, 44( 1): 5- 12. DOI: 10.3969/j.issn.1002-1949.2024.01.002.

    刘双庆, 杨建中, 杨婷, 等. 成人急性肝损伤诊疗急诊专家共识[J]. 中国急救医学, 2024, 44( 1): 5- 12. DOI: 10.3969/j.issn.1002-1949.2024.01.002.
    [5] ALQAHTANI SA, KLEINER DE, GHABRIL M, et al. Identification and characterization of cefazolin-induced liver injury[J]. Clin Gastroenterol Hepatol, 2015, 13( 7): 1328- 1336. e 2. DOI: 10.1016/j.cgh.2014.11.036.
    [6] Chinese Association of Integrative Medicine, China Association of Chinese Medicine, Chinese Medical Association. Guidelines for the integrated traditional Chinese and Western medicine diagnosis and treatment of acute-on-chronic liver failure[J]. J Clin Hepatol, 2023, 39( 7): 1547- 1552. DOI: 10.3969/j.issn.1001-5256.2023.07.006.

    中国中西医结合学会, 中华中医药学会, 中华医学会. 慢加急性肝衰竭中西医结合诊疗指南[J]. 临床肝胆病杂志, 2023, 39( 7): 1547- 1552. DOI: 10.3969/j.issn.1001-5256.2023.07.006.
    [7] WEI Q, LI L, ZENG XQ, et al. An analysis on the clinical features and risk factors associated with the prognosis of patients with drug-induced liver injury[J]. Explor Dig Dis, 2023: 100- 117. DOI: 10.37349/edd.2023.00021.
    [8] ZUO J, FAN YC. Progress in immunologic injury mechanism of hepatitis B virus-related acute-on-chronic liver failure[J]. J Crit Care Intern Med, 2024, 30( 3): 193- 199. DOI: 10.11768/nkjwzzzz20240301.

    左静, 范玉琛. 乙型肝炎相关慢加急性肝衰竭免疫损伤机制研究进展[J]. 内科急危重症杂志, 2024, 30( 3): 193- 199. DOI: 10.11768/nkjwzzzz2024-0301.
    [9] DONNELLY MC, HAYES PC, SIMPSON KJ. Role of inflammation and infection in the pathogenesis of human acute liver failure: Clinical implications for monitoring and therapy[J]. World J Gastroenterol, 2016, 22( 26): 5958- 5970. DOI: 10.3748/wjg.v22.i26.5958.
    [10] ZHANG N, YAN N, ZHOU ME, et al. Development and treatment of NLRP3 inflammatory corpuscule in acute and chronic liver diseases[J]. Liaoning J Tradit Chin Med, 2020, 47( 5): 217- 220. DOI: 10.13192/j.issn.1000-1719.2020.05.065.

    张娜, 晏旎, 周蒙恩, 等. NLRP3炎症小体在急慢性肝脏疾病发生和治疗中的研究进展[J]. 辽宁中医杂志, 2020, 47( 5): 217- 220. DOI: 10.13192/j.issn.1000-1719.2020.05.065.
    [11] WANG TS, WANG N, ZHANG RZ, et al. Role of immune response and inflammatory injury in the pathogenesis of liver failure[J]. J Clin Hepatol, 2020, 36( 6): 1415- 1419. DOI: 10.3969/j.issn.1001-5256.2020.06.050.

    王挺帅, 王娜, 张荣臻, 等. 免疫反应与炎症损伤在肝衰竭发病机制中的作用[J]. 临床肝胆病杂志, 2020, 36( 6): 1415- 1419. DOI: 10.3969/j.issn.1001-5256.2020.06.050.
    [12] WEI SS, MA WJ, ZHANG BK, et al. NLRP3 inflammasome: A promising therapeutic target for drug-induced toxicity[J]. Front Cell Dev Biol, 2021, 9: 634607. DOI: 10.3389/fcell.2021.634607.
    [13] LIU J, LUO RY, ZHANG YH, et al. Current status and perspective on molecular targets and therapeutic intervention strategy in hepatic ischemia-reperfusion injury[J]. Clin Mol Hepatol, 2024, 30( 4): 585- 619. DOI: 10.3350/cmh.2024.0222.
    [14] YANG T, QU XY, ZHAO JY, et al. Macrophage PTEN controls STING-induced inflammation and necroptosis through NICD/NRF2 signaling in APAP-induced liver injury[J]. Cell Commun Signal, 2023, 21( 1): 160. DOI: 10.1186/s12964-023-01175-4.
    [15] CHRISTOPOULOS PF, GJØLBERG TT, KRÜGER S, et al. Targeting the Notch signaling pathway in chronic inflammatory diseases[J]. Front Immunol, 2021, 12: 668207. DOI: 10.3389/fimmu.2021.668207.
    [16] GALLENSTEIN N, TICHY L, WEIGAND MA, et al. Notch signaling in acute inflammation and sepsis[J]. Int J Mol Sci, 2023, 24( 4): 3458. DOI: 10.3390/ijms24043458.
    [17] LÓPEZ-LÓPEZ S, MONSALVE EM, ROMERO DE ÁVILA MJ, et al. NOTCH3 signaling is essential for NF-κB activation in TLR-activated macrophages[J]. Sci Rep, 2020, 10( 1): 14839. DOI: 10.1038/s41598-020-71810-4.
    [18] SUN JC, CHEN Y, XU ZY, et al. Notch signaling in the tumor immune microenvironment of colorectal cancer: Mechanisms and therapeutic opportunities[J]. J Transl Med, 2025, 23( 1): 315. DOI: 10.1186/s12967-025-06282-z.
    [19] SHAO MJ, TIAN T, LUO JY, et al. Role of the NOTCH signaling pathway in cardiovascular diseases[J]. Chin J Heart Fail Cardiomyopathy, 2021, 5( 4): 275- 281. DOI: 10.3760/cma.j.cn101460-20201108-00113.

    邵梦娇, 田婷, 罗俊一, 等. NOTCH信号通路在心血管疾病中的作用[J]. 中华心力衰竭和心肌病杂志, 2021, 5( 4): 275- 281. DOI: 10.3760/cma.j.cn101460-20201108-00113.
    [20] WANG C, MA C, GONG LH, et al. Macrophage polarization and its role in liver disease[J]. Front Immunol, 2021, 12: 803037. DOI: 10.3389/fimmu.2021.803037.
    [21] CHEN WY, LIU YN, CHEN J, et al. The Notch signaling pathway regulates macrophage polarization in liver diseases[J]. Int Immunopharmacol, 2021, 99: 107938. DOI: 10.1016/j.intimp.2021.107938.
    [22] KEEWAN E, NASER SA. The role of Notch signaling in macrophages during inflammation and infection: Implication in rheumatoid arthritis[J]. Cells, 2020, 9( 1): 111. DOI: 10.3390/cells9010111.
    [23] TAN H, XU WJ, DING XQ, et al. Notch/NICD/RBP-J signaling axis regulates M1 polarization of macrophages mediated by advanced glycation end products[J]. Glycoconj J, 2022, 39( 4): 487- 497. DOI: 10.1007/s10719-022-10062-y.
    [24] AN N, YANG JX, WANG HQ, et al. Mechanism of mesenchymal stem cells in spinal cord injury repair through macrophage polarization[J]. Cell Biosci, 2021, 11( 1): 41. DOI: 10.1186/s13578-021-00554-z.
    [25] DUAN MY, LIU XG, YANG Y, et al. Orchestrated regulation of immune inflammation with cell therapy in pediatric acute liver injury[J]. Front Immunol, 2023, 14: 1194588. DOI: 10.3389/fimmu.2023.1194588.
    [26] CAO W, ZHAO CY, WANG W, et al. Role of the Notch signaling pathway in development of acute liver failure in a mouse model[J]. Chin J Hepatol, 2015, 23( 10): 765- 770. DOI: 10.3760/cma.j.issn.1007-3418.2015.10.011.

    曹伟, 赵彩彦, 王玮, 等. Notch信号通路在小鼠急性肝衰竭发生发展中的作用[J]. 中华肝脏病杂志, 2015, 23( 10): 765- 770. DOI: 10.3760/cma.j.issn.1007-3418.2015.10.011.
    [27] KACHANOVA O, LOBOV A, MALASHICHEVA A. The role of the Notch signaling pathway in recovery of cardiac function after myocardial infarction[J]. Int J Mol Sci, 2022, 23( 20): 12509. DOI: 10.3390/ijms23-2012509.
    [28] ZHANG PR. Endothelial Notch signaling regulates neutrophil transmigration via downregulating endomucin during hepatic ischemia/reperfusion injury[D]. Xi'an: Air Force Medical University of PLA, 2020.

    张沛然. 内皮细胞Notch信号通过endomucin参与肝脏缺血再灌注损伤中炎细胞招募的机制研究[D]. 西安: 中国人民解放军空军军医大学, 2020.
    [29] BANSAL R, VAN BAARLEN J, STORM G, et al. The interplay of the Notch signaling in hepatic stellate cells and macrophages determines the fate of liver fibrogenesis[J]. Sci Rep, 2015, 5: 18272. DOI: 10.1038/srep18272.
    [30] CHEN YH, YANG LH, LI XH. Advances in Mesenchymal stem cells regulating macrophage polarization and treatment of sepsis-induced liver injury[J]. Front Immunol, 2023, 14: 1238972. DOI: 10.3389/fimmu.2023.1238972.
    [31] CAPPENBERG A, KARDELL M, ZARBOCK A. Selectin-mediated signaling: Shedding light on the regulation of integrin activity in neutrophils[J]. Cells, 2022, 11( 8): 1310. DOI: 10.3390/cells11081310.
    [32] ZHANG K, AI WB, LIU CB, et al. Progress in understanding the relationship between Notch signaling pathway and hepatic stellate cell activation[J]. World Chin J Dig, 2013, 33: 3611- 3616.

    张凯, 艾文兵, 柳长柏, 等. Notch信号通路与HSC活化关系的研究进展[J]. 世界华人消化杂志, 2013, 33: 3611- 3616.
    [33] LIU ZY, LI WL, CAO Y, et al. Effects of the interaction of Notch and TLR4 pathways on inflammation and heart function in septic heart[J]. Open Life Sci, 2022, 17( 1): 744- 755. DOI: 10.1515/biol-2022-0076.
    [34] WANG L, ZHAO XP, XIE JJ, et al. The role of Hippo-YAP/TAZ and Notch signaling pathway in liver fibrosis[J]. Chem Life, 2023, 43( 3): 402- 407. DOI: 10.13488/j.smhx.20230140.

    王莉, 赵秀萍, 谢娇娇, 等. Hippo-YAP/TAZ与Notch信号通路在肝纤维化中的作用[J]. 生命的化学, 2023, 43( 3): 402- 407. DOI: 10.13488/j.smhx.20230140.
    [35] WEI X, WANG JP, HAO CQ, et al. Notch signaling contributes to liver inflammation by regulation of interleukin-22-producing cells in hepatitis B virus infection[J]. Front Cell Infect Microbiol, 2016, 6: 132. DOI: 10.3389/fcimb.2016.00132.
    [36] YOU J, ZHUANG L, MA YL, et al. Research advances in the imbalance of helper T lymphocyte subpopulations and cytokine network in patients with chronic hepatitis B[J]. World Chin J Dig, 2007, 15( 8): 791- 799. DOI: 10.3969/j.issn.1009-3079.2007.08.001.

    游晶, 庄林, 马永良, 等. 慢性乙型肝炎的Th细胞亚群及相关细胞因子网络失衡[J]. 世界华人消化杂志, 2007, 15( 8): 791- 799. DOI: 10.3969/j.issn.1009-3079.2007.08.001.
    [37] HU YQ, WU QG, WANG YL, et al. The molecular pathogenesis of triptolide-induced hepatotoxicity[J]. Front Pharmacol, 2022, 13: 979307. DOI: 10.3389/fphar.2022.979307.
    [38] ZHU YJ. Study on the regulatory effect of MDSCs on T cells in HBV-acute-on-chronic liver failure[D]. Urumqi: Xinjiang Medical University, 2023.

    朱玥洁. HBV相关慢加急性肝衰竭中MDSCs对T细胞的调节作用研究[D]. 乌鲁木齐: 新疆医科大学, 2023.
    [39] WANG B, SHEN ML, LI Y, et al. Correlation of Notch1 receptor expression in liver tissue with degree of hepatic fibrosis in patients with chronic hepatitis B[J]. World Chin J Dig, 2017, 25( 28): 2540- 2543. DOI: 10.11569/wcjd.v25.i28.2540.

    王变, 沈美龙, 李阳, 等. 慢性乙型肝炎患者肝组织Notch-1受体表达与肝纤维化相关性[J]. 世界华人消化杂志, 2017, 25( 28): 2540- 2543. DOI: 10.11569/wcjd.v25.28.2540.
    [40] DENG J, WANG XF, SUN RQ. Wogonin promotes Th17/Treg cell balance in rat models with autoimmune hepatitis[J]. Basic Clin Med, 2024, 44( 1): 77- 83. DOI: 10.16352/j.issn.1001-6325.2024.01.0077.

    邓娟, 王秀芳, 孙瑞青. 汉黄芩素促进自身免疫性肝炎模型大鼠Th17/Treg细胞平衡[J]. 基础医学与临床, 2024, 44( 1): 77- 83. DOI: 10.16352/j.issn.1001-6325.2024.01.0077.
    [41] ADAMS JM, JAFAR-NEJAD H. The roles of Notch signaling in liver development and disease[J]. Biomolecules, 2019, 9( 10): 608. DOI: 10.3390/biom9100608.
    [42] ZHOU X, WANG Z, HE XR, et al. Research advances in signaling pathways associated with potential anti-liver fibrosis drugs and targets[J]. J Clin Hepatol, 2023, 39( 12): 2932- 2941. DOI: 10.3969/j.issn.1001-5256.2023.12.027.

    周鑫, 王智, 何雪茹, 等. 潜在抗肝纤维化药物与靶点相关信号通路研究进展[J]. 临床肝胆病杂志, 2023, 39( 12): 2932- 2941. DOI: 10.3969/j.issn.1001-5256.2023.12.027.
    [43] YU HC, BAI L, YANG ZX, et al. Blocking Notch signal in myeloid cells alleviates hepatic ischemia reperfusion injury by repressing the activation of NF-κB through CYLD[J]. Sci Rep, 2016, 6: 32226. DOI: 10.1038/srep32226.
    [44] GAO CC, BAI J, HAN H, et al. The versatility of macrophage heterogeneity in liver fibrosis[J]. Front Immunol, 2022, 13: 968879. DOI: 10.3389/fimmu.2022.968879.
    [45] MINNIS-LYONS SE, FERREIRA-GONZÁLEZ S, ALEKSIEVA N, et al. Notch-IGF1 signaling during liver regeneration drives biliary epithelial cell expansion and inhibits hepatocyte differentiation[J]. Sci Signal, 2021, 14( 688): eaay9185. DOI: 10.1126/scisignal.aay9185.
    [46] ZHANG CY, SUN CF, ZHAO YB, et al. Signaling pathways of liver regeneration: Biological mechanisms and implications[J]. iScience, 2023, 27( 1): 108683. DOI: 10.1016/j.isci.2023.108683.
    [47] XIONG F, ZHANG YC, LI T, et al. A detailed overview of quercetin: Implications for cell death and liver fibrosis mechanisms[J]. Front Pharmacol, 2024, 15: 1389179. DOI: 10.3389/fphar.2024.1389179.
  • 加载中
图(1)
计量
  • 文章访问数:  2
  • HTML全文浏览量:  1
  • PDF下载量:  2
  • 被引次数: 0
出版历程
  • 收稿日期:  2025-03-26
  • 录用日期:  2025-05-12
  • 出版日期:  2025-11-25
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回